MALAT1 and colorectal carcinoma: As one of the differentially expressed lncRNAs, MALAT1 had higher expression levels in recurrent primary and metastatic sites, relative to non-recurrent primary tumors (Fig. 1b), and this result was validated by real-time PCR in 124 CRC primary and metastatic tissues (Fig. 1c).